Department of Molecular and Cellular Medicine, Texas A&M University, College Station, TX, USA.
Medical Sciences Library, Texas A&M University, College Station, TX, USA.
Environ Sci Pollut Res Int. 2022 May;29(24):35583-35598. doi: 10.1007/s11356-022-19333-5. Epub 2022 Mar 4.
Lead (Pb) poisoning is a major public health concern in environmental justice communities of the USA and in many developing countries. There is no identified safety threshold for lead in blood, as low-level Pb exposures can lead to severe toxicity in highly susceptible individuals and late onset of diseases from early-life exposure. However, identifying "susceptibility genes" or "early exposure biomarkers" remains challenging in human populations. There is a considerable variation in susceptibility to harmful effects from Pb exposure in the general population, likely due to the complex interplay of genetic and/or epigenetic factors. This systematic review summarizes current state of knowledge on the role of genetic and epigenetic factors in determining individual susceptibility in response to environmental Pb exposure in humans and rodents. Although a number of common genetic and epigenetic factors have been identified, the reviewed studies, which link these factors to various adverse health outcomes following Pb exposure, have provided somewhat inconsistent evidence of main health effects. Acknowledging the compelling need for new approaches could guide us to better characterize individual responses, predict potential adverse outcomes, and identify accurate and usable biomarkers for Pb exposure to improve mitigation therapies to reduce future adverse health outcomes of Pb exposure.
铅(Pb)中毒是美国环境正义社区和许多发展中国家的主要公共卫生关注点。血液中铅的安全阈值尚未确定,因为低水平的 Pb 暴露可能会导致高度敏感个体的严重毒性,以及早期暴露导致的疾病的迟发性发作。然而,在人类群体中确定“易感基因”或“早期暴露生物标志物”仍然具有挑战性。在普通人群中,对 Pb 暴露有害影响的易感性存在很大差异,这可能是由于遗传和/或表观遗传因素的复杂相互作用所致。本系统综述总结了目前关于遗传和表观遗传因素在决定人类和啮齿动物对环境 Pb 暴露的个体易感性方面的作用的知识现状。尽管已经确定了一些常见的遗传和表观遗传因素,但所综述的研究将这些因素与 Pb 暴露后各种不良健康结果联系起来,为主要健康影响提供了一些不一致的证据。承认对新方法的强烈需求可以指导我们更好地描述个体反应、预测潜在的不良结果,并确定用于 Pb 暴露的准确和可用的生物标志物,以改善缓解治疗,减少 Pb 暴露未来的不良健康结果。